Monthly Archives: September 2019

There have been conflicting results from studies comparing the risk of hepatocellular carcinoma (HCC) in patients with chronic hepatitis B virus (HBV) infection treated with tenofovir disoproxil fumarate (TDF) vs those treated with entecavir. We compar… Continue reading →

We performed a large, multicenter randomized controlled trial to determine the efficacy and safety of early colonoscopy on outcomes of patients with acute lower-gastrointestinal bleeding (ALGIB). Continue reading →

Although colorectal cancer (CRC) screening has reduced the incidence and mortality from CRC, chemoprevention strategies have potential to further reduce CRC incidence and mortality. Chemoprevention agents might be used for average-risk as well as high-… Continue reading →

Recommendation of surveillance colonoscopy should be based on risk of colorectal cancer and death after adenoma removal. We aimed to develop risk classification system based on colorectal cancer incidence and mortality following adenoma removal. Continue reading →

Non-invasive scoring systems are used to identify persons with advanced liver fibrosis. We investigated the ability of scoring systems to identify individuals in the general population at risk for future liver-related events. Continue reading →

Scoring systems are suboptimal for determining risk in patients with gastrointestinal bleeding (UGIB); these might be improved by a machine learning model. We used machine learning to develop a model to calculate risk of hospital-based intervention or … Continue reading →